An enhanced CRISPR repressor for targeted mammalian gene regulation
Nan Cher Yeo,Alejandro Chavez,Alissa Lance-Byrne,Yingleong Chan,Yingleong Chan,David J. Menn,Denitsa Milanova,Denitsa Milanova,Chih-Chung Kuo,Xiaoge Guo,Xiaoge Guo,Sumana Sharma,Angela Tung,Ryan J Cecchi,Marcelle Tuttle,Swechchha Pradhan,Elaine T. Lim,Elaine T. Lim,Noah Davidsohn,Noah Davidsohn,Mo R. Ebrahimkhani,Mo R. Ebrahimkhani,James J. Collins,Nathan E. Lewis,Samira Kiani,George M. Church,George M. Church +26 more
TL;DR: An improved Cas9 repressor based on the C-terminal fusion of a rationally designed bipartite repressor domain, KRAB–MeCP2, to nuclease-dead Cas9 is described, demonstrating the system’s superiority in silencing coding and noncoding genes and enabling new architectures of synthetic genetic circuits.
read more
Abstract: The RNA-guided endonuclease Cas9 can be converted into a programmable transcriptional repressor, but inefficiencies in target-gene silencing have limited its utility. Here we describe an improved Cas9 repressor based on the C-terminal fusion of a rationally designed bipartite repressor domain, KRAB-MeCP2, to nuclease-dead Cas9. We demonstrate the system's superiority in silencing coding and noncoding genes, simultaneously repressing a series of target genes, improving the results of single and dual guide RNA library screens, and enabling new architectures of synthetic genetic circuits.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
oFlowSeq: A multiplexed quantitative approach to identify genes affecting cell type enrichment using mosaic CRISPR-Cas9 edited cerebral organoids
01 Aug 2022
TL;DR: al. as discussed by the authors presented a method to identify genotype-to-cell type imbalances in an unbiased, multiple-xed, quantitative manner using oFlowSeq.
Orthogonal Control of Gene Expression in Plants Using Synthetic Promoters and CRISPR-Based Transcription Factors
03 Jan 2022
TL;DR: In this article , a panel of three mutually orthogonal promoters that can be acted on by artificial gRNAs bound by CRISPR regulators were designed, and a fully artificial Orthogonal Control System (OCS) was implemented.
Strategies to Study the Functions of Pseudogenes in Mouse Models of Cancer.
Ilah Bok,Florian A. Karreth +1 more
TL;DR: In this article, the authors present various strategies to investigate pseudogenes in genetically engineered mouse models and discuss advantages and disadvantages of the different approaches and discuss the advantages of each of them.
sgRNA level is a major factor affecting CRISPRi knockdown efficiency in K562 cells
TL;DR: In this article, the authors determined the knockdown efficiency and the expression level of the dCas9 protein /sgRNA level by flow cytometry, and the cell clone with the highest KRAB-dCas9 expression level achieved effective CRISPRi knockdown, and is statistically different from other clones.
References
Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method
TL;DR: The 2-Delta Delta C(T) method as mentioned in this paper was proposed to analyze the relative changes in gene expression from real-time quantitative PCR experiments, and it has been shown to be useful in the analysis of realtime, quantitative PCR data.
168.2K
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Martin Jinek,Krzysztof Chylinski,Krzysztof Chylinski,Ines Fonfara,Michael H. Hauer,Jennifer A. Doudna,Emmanuelle Charpentier +6 more
TL;DR: This study reveals a family of endonucleases that use dual-RNAs for site-specific DNA cleavage and highlights the potential to exploit the system for RNA-programmable genome editing.
16.2K
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong,Le Cong,F. Ann Ran,F. Ann Ran,David M. Cox,David M. Cox,Shuailiang Lin,Shuailiang Lin,Robert P. J. Barretto,Naomi Habib,Patrick D. Hsu,Patrick D. Hsu,Xuebing Wu,Wenyan Jiang,Luciano A. Marraffini,Feng Zhang +15 more
TL;DR: The type II prokaryotic CRISPR (clustered regularly interspaced short palindromic repeats)/Cas adaptive immune system has been shown to facilitate RNA-guided site-specific DNA cleavage as discussed by the authors.
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong,F. A. Ran,David Benjamin Turitz Cox,Shuailiang Lin,Robert P. J. Barretto,Naomi Habib,Patrick D. Hsu,Xuebing Wu,Wenyan Jiang,Luciano A. Marraffini,Feng Zhang +10 more
- 01 Feb 2013
TL;DR: Two different type II CRISPR/Cas systems are engineered and it is demonstrated that Cas9 nucleases can be directed by short RNAs to induce precise cleavage at endogenous genomic loci in human and mouse cells, demonstrating easy programmability and wide applicability of the RNA-guided nuclease technology.
12K
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali,Luhan Yang,Kevin M. Esvelt,John Aach,Marc Güell,James E. DiCarlo,Julie E. Norville,George M. Church,George M. Church +8 more
TL;DR: The type II bacterial CRISPR system is engineer to function with custom guide RNA (gRNA) in human cells to establish an RNA-guided editing tool for facile, robust, and multiplexable human genome engineering.